TrialEuropean journal of medical research2009

Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT).

Keikawus Arasteh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.